ELISA検査の2030年までの市場予測：タイプ、技術、用途、エンドユーザー、地域別の世界分析

Stratistics MRCによると、世界のELISA検査市場は2023年に25億5,000万米ドルを占め、予測期間中にCAGR 8.9％で成長し、2030年には46億4,000万米ドルに達すると予測されています。

酵素結合免疫吸着法は、血液中の抗体、ホルモン、ペプチド、タンパク質の同定と定量に使用される標準的なアッセイ技術です。ELISA検査は、エンドトキシンアッセイやタンパク質定量などの医薬品の品質管理検査でよく使用され、多くのウイルス性疾患の診断に極めて重要です。ELISAは、植物病理学や医学における診断技術であると同時に、多くの異なる分野における品質管理検査でも用いられています。酵素結合免疫吸着測定法（ELISA）検査は、医学や植物病理学を含む様々な分野で、品質保証検査やスクリーニング機器として頻繁に使用されています。

世界保健機関（WHO）によると、2020年には約3,770万人がHIVに感染しています。

早期かつ正確な診断に対する需要の高まり

効果的な疾病管理と治療は、早期かつ正確な診断に依存しています。ELISA検査の高い感度と特異性により、医療従事者は患者サンプル中の特定のバイオマーカーを同定し測定することができます。早期診断により迅速な治療開始が可能となり、患者の治療成績が大幅に向上します。さらに、ヘルスケア従事者は、これらのバイオマーカーを迅速に認識することで、効果的な治療技術に介入し、迅速に実施することができます。ELISA検査市場は、早期かつ正確な診断の需要により拡大しています。

厳しい政府規制

診断用医薬品は、医師による診断に使用されることを意図しているにもかかわらず、医療機器に分類される製品もあるため、マーケティングは困難です。時間と費用がかかり、不確実なプロセスである臨床試験を成功させなければ、そのような機器を発売することはできないです。国によってこれらの機器の認証に関する規則が異なるという現実は、国際企業にとって大きな課題です。さらに、製品開発プロセス中にFDAのような様々な規制当局が規則を変更した場合、潜在的な製品のイントロダクション遅れが生じる可能性があります。こうした厳しい政府規制は、市場成長の大きな障壁となっています。

技術開発

ELISA検査市場は、自動化システムの構築、多重化能力、アッセイの感度と特異性の向上といった技術開発の恩恵を受けています。技術改良により自動ELISAシステムが構築され、手作業が排除され、効率が向上しました。自動化されたプラットフォームでは、複数のサンプルを同時に扱うことができ、検査手順を合理化し、スループットを向上させることができます。さらに、ターンアラウンドタイムを短縮し、検査室の効率を高めることで、このテクノロジーはヘルスケア従事者が効率的に大量の検査を実施することを可能にします。ELISA検査は、有効性、正確性、生産性を向上させるこれらの新興市場開拓の結果、多くのヘルスケア現場で広く使用されるようになってきており、これが市場需要を牽引しています。

代替技術の競合

ポイントオブケア検査（POCT）機器、次世代シークエンシング（NGS）、分子診断技術（PCRなど）などの代替診断技術は、市場でELISA検査と競合しています。これらの技術革新には、迅速な納期、より高い感度、一度に複数の分析物を検出する能力などの利点があります。特に分子診断学が明らかに優位性を持つ分野では、これらの技術が発展し、より広く利用できるようになれば、ELISA検査に取って代わられたり、競合したりする可能性があります。ELISA検査の市場は、こうした代替技術の利用可能性と普及によって脅かされる可能性があります。

COVID-19の影響

当初、COVID-19の流行では、患者の病気を特定するための特定の診断検査はありません。当初、代替診断法が試みられたが、あまり成功しなかっています。さらに、特定のCOVID-19診断検査が利用できなかったため、診断キットメーカーはCOVID-19診断製品を販売する有益なチャンスを得た。このチャンスを利用して、多くの老舗企業だけでなく、各国の新興企業もCOVID-19診断キットをローカル市場だけでなく世界市場にも提供しました。

予測期間中、サンドイッチELISAセグメントが最大となる見込み

サンドイッチELISAセグメントが最大のシェアを占めると推定されます。抗原は、2層の抗体（捕捉抗体と検出抗体）からなるサンドイッチELISAを用いて測定されます。標的抗原上の2つの抗原部位が抗体と結合する準備が整っています。サンドイッチELISA法では、モノクローナル抗体またはポリクローナル抗体が抗体の捕捉と認識に使用されます。サンドイッチELISAは免疫学的反応の検出に最も適しており、この事実が市場の拡大を促進しています。サンドイッチELISAは、様々な抗体を用いて同じ抗原を認識・検出するもので、最も感度の高い検査法でもあります。また、柔軟性が高く、特異性も高いです。

予測期間中、感染症分野のCAGRが最も高くなると予想される

感染症セグメントは予測期間中に有利な成長を遂げると予測されています。慢性疾患や感染性疾患の有病率の増加により、感染症は現在ELISA市場のアプリケーション分野をリードしています。HIV、HBV、HCV、HTLV、ジフテリア、ジアルジア症、その他いくつかの血液感染性疾患酵素結合免疫吸着測定法（ELISA）検査市場のアプリケーション分野は、迅速で正確な所見が得られ、感度が高く、自動化され簡単に実施でき、放射性物質や高価な放射線装置を必要としないため、ELISA検査が支配的です。

最大のシェアを占める地域

北米は、ヘルスケアシステムが高度に発達しており、医療機器の利用が拡大していることから、予測期間中に最大の市場シェアを占めました。糖尿病や慢性疾患などの疾患や疾病に対する製薬会社や政府機関による研究開発費の増加も、予測期間中の同地域のELISA検査市場の成長に寄与しています。

CAGRが最も高い地域：

欧州は、新興国における可処分所得とヘルスケア支出の増加により、予測期間中に収益性の高い成長が見込まれます。ELISA検査市場は、先進国での医療機器使用の増加により、今後数年間で成長すると予測されます。さらに、高齢者人口が多く、研究開発に多額の投資が行われていることから、予測期間中、欧州大陸では非伝染性疾患の頻度が上昇し、ELISA検査の需要が増加することも予想されます。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレーヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• テクノロジー分析
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のELISA検査市場：タイプ別

• 間接ELISA
• サンドイッチELISA
• 競合ELISA
• 複数のポータブルELISA

第6章 世界のELISA検査市場：技術別

• 化学発光
• 比色分析
• 蛍光

第7章 世界のELISA検査市場：用途別

• 感染症
• タンパク質の定量
• ワクチン開発
• がん
• 免疫学
• その他の用途

第8章 世界のELISA検査市場：エンドユーザー別

• 製薬会社およびバイオテクノロジー企業
• 学術研究センター
• 臨床検査室
• 病院と診断センター
• その他のエンドユーザー

第9章 世界のELISA検査市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Abbott Laboratories
• Danaher Corporation
• BioMerieux SA
• Quidel Corporation
• Siemens Healthineers
• Sysmex Corporation
• Bio-Rad Laboratories
• Ortho Clinical Diagnostics
• Thermo Fisher Scientific, Inc.
• ZEUS Scientific, Inc.
• Hoffmann-La Roche AG
• PerkinElmer, Inc.
• Enzo Life Sciences, Inc.
• Agilent Technologies, Inc.
• R&D Systems, Inc.
• Bruker
• Eurofins Scientific
• ELISA Technologies, Inc
• BioLegend, Inc

List of Tables

• Table 1 Global Elisa Tests Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
• Table 4 Global Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
• Table 5 Global Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
• Table 6 Global Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
• Table 7 Global Elisa Tests Market Outlook, By Technology(2021-2030) ($MN)
• Table 8 Global Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
• Table 9 Global Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
• Table 10 Global Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
• Table 11 Global Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
• Table 12 Global Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
• Table 13 Global Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
• Table 14 Global Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
• Table 15 Global Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
• Table 16 Global Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
• Table 17 Global Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 18 Global Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
• Table 19 Global Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 20 Global Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
• Table 21 Global Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
• Table 22 Global Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
• Table 23 Global Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 24 North America Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
• Table 25 North America Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
• Table 26 North America Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
• Table 27 North America Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
• Table 28 North America Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
• Table 29 North America Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
• Table 30 North America Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
• Table 31 North America Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
• Table 32 North America Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
• Table 33 North America Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
• Table 34 North America Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
• Table 35 North America Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
• Table 36 North America Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
• Table 37 North America Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
• Table 38 North America Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
• Table 39 North America Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
• Table 40 North America Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 41 North America Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
• Table 42 North America Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 43 North America Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
• Table 44 North America Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
• Table 45 North America Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
• Table 46 North America Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 47 Europe Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
• Table 48 Europe Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
• Table 49 Europe Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
• Table 50 Europe Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
• Table 51 Europe Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
• Table 52 Europe Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
• Table 53 Europe Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
• Table 54 Europe Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
• Table 55 Europe Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
• Table 56 Europe Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
• Table 57 Europe Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
• Table 58 Europe Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
• Table 59 Europe Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
• Table 60 Europe Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
• Table 61 Europe Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
• Table 62 Europe Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
• Table 63 Europe Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 64 Europe Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
• Table 65 Europe Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 66 Europe Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
• Table 67 Europe Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
• Table 68 Europe Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
• Table 69 Europe Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 70 Asia Pacific Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
• Table 71 Asia Pacific Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
• Table 72 Asia Pacific Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
• Table 73 Asia Pacific Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
• Table 74 Asia Pacific Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
• Table 75 Asia Pacific Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
• Table 76 Asia Pacific Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
• Table 77 Asia Pacific Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
• Table 78 Asia Pacific Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
• Table 79 Asia Pacific Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
• Table 80 Asia Pacific Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
• Table 81 Asia Pacific Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
• Table 82 Asia Pacific Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
• Table 83 Asia Pacific Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
• Table 84 Asia Pacific Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
• Table 85 Asia Pacific Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
• Table 86 Asia Pacific Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 87 Asia Pacific Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
• Table 88 Asia Pacific Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 89 Asia Pacific Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
• Table 90 Asia Pacific Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
• Table 91 Asia Pacific Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
• Table 92 Asia Pacific Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 93 South America Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
• Table 94 South America Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
• Table 95 South America Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
• Table 96 South America Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
• Table 97 South America Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
• Table 98 South America Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
• Table 99 South America Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
• Table 100 South America Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
• Table 101 South America Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
• Table 102 South America Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
• Table 103 South America Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
• Table 104 South America Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
• Table 105 South America Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
• Table 106 South America Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
• Table 107 South America Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
• Table 108 South America Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
• Table 109 South America Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 110 South America Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
• Table 111 South America Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 112 South America Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
• Table 113 South America Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
• Table 114 South America Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
• Table 115 South America Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 116 Middle East & Africa Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
• Table 117 Middle East & Africa Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
• Table 118 Middle East & Africa Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
• Table 119 Middle East & Africa Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
• Table 120 Middle East & Africa Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
• Table 121 Middle East & Africa Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
• Table 122 Middle East & Africa Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
• Table 123 Middle East & Africa Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
• Table 124 Middle East & Africa Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
• Table 125 Middle East & Africa Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
• Table 126 Middle East & Africa Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
• Table 127 Middle East & Africa Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
• Table 128 Middle East & Africa Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
• Table 129 Middle East & Africa Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
• Table 130 Middle East & Africa Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
• Table 131 Middle East & Africa Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
• Table 132 Middle East & Africa Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 133 Middle East & Africa Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
• Table 134 Middle East & Africa Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 135 Middle East & Africa Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
• Table 136 Middle East & Africa Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
• Table 137 Middle East & Africa Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
• Table 138 Middle East & Africa Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Elisa Tests Market is accounted for $2.55 billion in 2023 and is expected to reach $4.64 billion by 2030 growing at a CAGR of 8.9% during the forecast period. The enzyme-linked immune sorbent assay is the standard assay technique used to identify and quantify antibodies, hormones, peptides, and proteins in the blood. The ELISA test is often used in pharmaceutical quality control tests like endotoxin assays and protein quantification and is crucial in the diagnosis of a number of viral diseases. ELISA is a diagnostic technique in plant pathology and medicine as well as a quality control checks in many different sectors. Enzyme-linked immune sorbent assay (ELISA) testing is frequently used as a quality assurance check and screening instrument in a variety of fields, including medicine and plant pathology.

According to the World Health Organization (WHO), around 37.7 million people had HIV in 2020.

Market Dynamics:

Driver:

Rising demand for early and accurate diagnosis

Effective illness management and therapy rely on early and precise diagnosis. The high sensitivity and specificity of Elisa testing enable medical personnel to identify and measure particular biomarkers in patient samples. Early diagnosis enables quick treatment beginning, which can greatly enhance patient results. Additionally, healthcare practitioners can intervene and swiftly implement effective treatment techniques by quickly recognizing these biomarkers. The market for Elisa testing is expanding due to the demand for early and accurate diagnosis.

Restraint:

Stringent government regulations

The marketing of diagnostic products is difficult because some products are categorized as medical devices even though they are intended for use in diagnostic procedures by doctors. Without successfully completing clinical trials, which are a time-consuming, expensive, and uncertain process, such devices cannot be launched. The reality that different countries have different rules for these devices' certification is a significant challenge for international corporations. Additionally, any modifications to rules made by various regulatory agencies, like the FDA, during the product development process may cause a delay in the introduction of potential products. These stringent government regulations are the major barriers to market growth.

Opportunity:

Technological developments

The market for Elisa testing has benefited from technological developments such as the creation of automated systems, the ability to multiplex and enhanced sensitivity and specificity of assays. Technological improvements have led to the creation of automated Elisa systems, excluding manual labor and enhancing efficiency. Multiple samples can be handled simultaneously by automated platforms, streamlining the testing procedure and boosting throughput. Furthermore, by speeding up turnaround times and increasing laboratory efficiency, this technology enables healthcare practitioners to efficiently perform a higher volume of tests. Elisa tests are becoming more widely used in many healthcare settings as a result of these developments, which improve their effectiveness, accuracy, and productivity, which drives market demand.

Threat:

Alternative technologies' competition

Alternative diagnostic technologies, such as point-of-care testing (POCT) devices, next-generation sequencing (NGS), and molecular diagnostic techniques (e.g., PCR), compete with Elisa tests on the market. These innovations have benefits like quicker turnaround times, greater sensitivity, and the capacity to detect multiple analytes at once. Elisa tests may be replaced or competed with as these technologies develop and become more widely available, especially in areas where molecular diagnostics have clear advantages. The market for Elisa tests may be threatened by the availability and uptake of these substitute technologies.

COVID-19 Impact

Initially, in the COVID-19 epidemic, there were no particular diagnostic tests available to identify the illness in patients. Initially, alternative diagnostic procedures were attempted, but they were not very successful. Additionally, due to the unavailability of certain COVID-19 diagnostic tests, diagnostic kit manufacturers had profitable chances to market their COVID-19 diagnostic products. Utilizing this chance, many established companies as well as a few start-ups from different nations offered COVID-19 diagnostic kits to local as well as global markets.

The sandwich ELISA segment is expected to be the largest during the forecast period

The sandwich ELISA segment is estimated to hold the largest share. Antigen is measured using a sandwich ELISA, which consists of two layers of antibodies (the capture antibody and the detection antibody). Two antigenic sites on the target antigens are ready to bind to the antibodies. In sandwich ELISA techniques, monoclonal or polyclonal antibodies are employed to capture and recognize antibodies. Sandwich ELISA works the best for detecting immunological responses, and this fact is promoting market expansion. Sandwich ELISA, which uses a variety of antibodies to bind to the same antigen for recognition or detection, is also the most sensitive test available. It also has a high degree of flexibility and higher specificity.

The infectious diseases segment is expected to have the highest CAGR during the forecast period

The infectious diseases segment is anticipated to have lucrative growth during the forecast period, due to an increase in the prevalence of chronic illnesses and infectious disorders, infectious diseases are now leading the ELISA market's application sector. HIV, HBV, HCV, HTLV, Diphtheria, Giardiasis, and several other infectious blood-borne illnesses The application sector of the enzyme-linked immune sorbent assay (ELISA) testing market is dominated by ELISA tests because they provide quick and accurate findings, have high sensitivity, are automated and simple to perform, and do not require radioactive materials or expensive radiation gear.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the highly developed healthcare system and the growing use of medical gadgets. Rising R&D expenditures by pharmaceutical firms and government organizations for disorders and diseases, including diabetes and chronic illnesses, would also contribute to the market growth for ELISA tests in this region during the projected period.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period due to the rising disposable income and healthcare expenditure in emerging nations. The market for ELISA tests is anticipated to grow in the coming years as a result of the rising use of medical equipment in developed nations. Additionally, due to the large geriatric population and significant investment in research and development, in the projected time frame, it is also anticipated that the rising frequency of non-communicable diseases on the European continent will increase demand for ELISA testing.

Key players in the market

Some of the key players in the Elisa Tests Market include: Abbott Laboratories, Danaher Corporation, BioMerieux SA, Quidel Corporation, Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., ZEUS Scientific, Inc., Hoffmann-La Roche AG, PerkinElmer, Inc., Enzo Life Sciences, Inc., Agilent Technologies, Inc., R&D Systems, Inc., Bruker, Eurofins Scientific, ELISA Technologies, Inc and BioLegend, Inc.

Key Developments:

In May 2023, Abbott, a global leader in health care and nutrition, has partnered with Real Madrid, one of the most successful and popular football clubs in the world, to inaugurate the Abbott-Real Madrid Innovation Lab, a space for collaboration and research on the future of sports physiology and nutrition.

In March 2023, Thermo Fisher Scientific, the world leader in serving science, and Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T cell therapies for solid tumors, announced an update to their strategic collaboration to further the development of manufacturing processes for new cancer treatments.

In November 2020, Siemens Healthineers announced that its SARS-CoV-2 IgG Antibody Test has proven to evaluate neutralizing antibodies and has gained CE Marking. This test is the better version of its previously launched COVID-19 antibody test.

Types Covered:

• Indirect ELISA
• Sandwich ELISA
• Competitive ELISA
• Multiple and Portable ELISA

Technologies Covered:

• Chemiluminescent
• Colorimetric
• Fluorescent

Applications Covered:

• Infectious Diseases
• Protein Quantitation
• Vaccine Development
• Cancer
• Immunology
• Other Applications

End Users Covered:

• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Clinical Laboratories
• Hospitals and Diagnostic Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 TechnologyAnalysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Elisa Tests Market, By Type

• 5.1 Introduction
• 5.2 Indirect ELISA
• 5.3 Sandwich ELISA
• 5.4 Competitive ELISA
• 5.5 Multiple and Portable ELISA

6 Global Elisa Tests Market, By Technology

• 6.1 Introduction
• 6.2 Chemiluminescent
• 6.3 Colorimetric
• 6.4 Fluorescent

7 Global Elisa Tests Market, By Application

• 7.1 Introduction
• 7.2 Infectious Diseases
• 7.3 Protein Quantitation
• 7.4 Vaccine Development
• 7.5 Cancer
• 7.6 Immunology
• 7.7 Other Applications

8 Global Elisa Tests Market, By End User

• 8.1 Introduction
• 8.2 Pharmaceutical and Biotech Companies
• 8.3 Academic Research Centers
• 8.4 Clinical Laboratories
• 8.5 Hospitals and Diagnostic Centers
• 8.6 Other End Users

9 Global Elisa Tests Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Abbott Laboratories
• 11.2 Danaher Corporation
• 11.3 BioMerieux SA
• 11.4 Quidel Corporation
• 11.5 Siemens Healthineers
• 11.6 Sysmex Corporation
• 11.7 Bio-Rad Laboratories
• 11.8 Ortho Clinical Diagnostics
• 11.9 Thermo Fisher Scientific, Inc.
• 11.10 ZEUS Scientific, Inc.
• 11.11 Hoffmann-La Roche AG
• 11.12 PerkinElmer, Inc.
• 11.13 Enzo Life Sciences, Inc.
• 11.14 Agilent Technologies, Inc.
• 11.15 R&D Systems, Inc.
• 11.16 Bruker
• 11.17 Eurofins Scientific
• 11.18 ELISA Technologies, Inc
• 11.19 BioLegend, Inc